Actively Recruiting
To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
Led by Pierre Fabre Medicament · Updated on 2025-07-24
368
Participants Needed
3
Research Sites
177 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study looks at how well oral vinorelbine works in treating advanced breast cancer. It looks at women who have already had this treatment or are currently having it.
CONDITIONS
Official Title
To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 18 years or older (19 years or older in Algeria at treatment start)
- Confirmed diagnosis of locally advanced or metastatic breast cancer eligible for chemotherapy
- Started oral vinorelbine treatment between January 2011 and December 2020 for retrospective group, or starting treatment at enrollment for prospective group
- Willing and able to fill out quality of life, PPQ, and WPAI questionnaires for prospective group
- Provided informed consent or non-opposition for use of data according to local rules
You will not qualify if you...
- No exclusion criteria for patients in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Centre Hospitalo-Universitaire Mustapha, Hopital Mustapha, Place du 1er Mai 1945, Sidi M'Hamed
Algiers, Algeria, 16000
Actively Recruiting
2
Tianjing Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China, 360060
Actively Recruiting
3
Azienda Ospedaliera San Gerardo U.O. Oncologia Medica
Monza, Italy, 20052
Actively Recruiting
Research Team
C
Cynthia Mourad, PharmD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here